HighQC™ Human Mobilized Peripheral Blood Mononuclear Cells

Description

HighQC™ Human Mobilized Peripheral Blood Mononuclear Cells are isolated from G-CSF-mobilized peripheral blood, enriched for CD34⁺ hematopoietic stem/progenitor cells (HSPCs) and activated immune subsets. They mainly include lymphocytes (T cells, B cells, and NK cells) and monocyte. As the core carrier of innate and adaptive immunity, T cells in PBMCs mediate cellular immunity, B cells produce antibodies, NK cells perform killing functions, and monocytes can differentiate into macrophages/dendritic cells to participate in antigen presentation. These PBMCs exhibit enhanced proliferative capacity and engraftment potential, making them ideal for transplant research, immunotherapy, and regenerative medicine. The mobilization process increases yields of rare populations (e. g., CD34⁺ cells) while maintaining robust functionality in colony-forming assays and in vivo models. These HighQC PBMCs represent a highly functional mobilized PBMC population, providing well-characterized peripheral blood mononuclear cells with superior engraftment and immune activity, exemplifying the quality and consistency of HighQC mobilized PBMC for advanced research applications.